In the News

Par Pharma Suit Tests FDA's Drug Pricing Pushback, Law360

October 30, 2017

Efforts by the U.S. Food and Drug Administration to combat dramatic price spikes for prescription drugs are being tested by a new Par Pharmaceutical lawsuit accusing regulators of improperly letting compounding pharmacies sell cheaper copycats, attorneys say.

View the full Law360 article >>